Mark R. Hurtt
Profile
Mark R.
Hurtt has been Chief Medical Officer of Alseres Pharmaceuticals, Inc. since October 2005.
Previously, he was Senior Director-Clinical Research of Neurogen Corporation, Director-Drug Development and Director-Clinical Research of Pfizer Global Research and Development and Assistant Professor of Neurology and Pathology at the University of Pittsburgh.
Dr. Hurtt received an MD degree from Jefferson Medical College
Former positions of Mark R. Hurtt
| Companies | Position | End |
|---|---|---|
| University of Pittsburgh | Corporate Officer/Principal | - |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Chief Tech/Sci/R&D Officer | - |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Chief Tech/Sci/R&D Officer | - |
| ALSERES PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Mark R. Hurtt
| Sidney Kimmel Medical College | Doctorate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| ALSERES PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
- Stock Market
- Insiders
- Mark R. Hurtt
